Package 25021-312-04

{"route": ["INTRAVENOUS"], "spl_id": "b4eb5dd2-5e25-4ecc-ac57-8897f2b6984a", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["a76b2cff-7029-4607-88db-9921ec2842b6"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-312-02)  / 2 mL in 1 VIAL", "package_ndc": "25021-312-02", "marketing_start_date": "20210315"}, {"sample": false, "description": "5 VIAL in 1 CARTON (25021-312-04)  / 4 mL in 1 VIAL", "package_ndc": "25021-312-04", "marketing_start_date": "20210315"}], "brand_name": "Verapamil Hydrochloride", "product_id": "25021-312_b4eb5dd2-5e25-4ecc-ac57-8897f2b6984a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "25021-312", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA214361", "marketing_category": "ANDA", "marketing_start_date": "20210315", "listing_expiration_date": "20261231"}